These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

190 related items for PubMed ID: 9039200

  • 21. Efficacy and safety of once-daily luliconazole 1% cream in patients ≥12 years of age with interdigital tinea pedis: a phase 3, randomized, double-blind,vehicle-controlled study.
    Jarratt M, Jones T, Adelglass J, Bucko A, Pollak R, Roman-Miranda A, Olin JT, Swinyer L.
    J Drugs Dermatol; 2014 Jul; 13(7):838-46. PubMed ID: 25007368
    [Abstract] [Full Text] [Related]

  • 22. Topical treatment with butenafine significantly lowers relapse rate in an interdigital tinea pedis model in guinea pigs.
    Arika T, Yokoo M, Yamaguchi H.
    Antimicrob Agents Chemother; 1992 Nov; 36(11):2523-5. PubMed ID: 1489197
    [Abstract] [Full Text] [Related]

  • 23. Evaluation of the efficacy of ciclopirox 0.77% gel in the treatment of tinea pedis interdigitalis (dermatophytosis complex) in a randomized, double-blind, placebo-controlled trial.
    Gupta AK, Skinner AR, Cooper EA.
    Int J Dermatol; 2005 Jul; 44(7):590-3. PubMed ID: 15985032
    [Abstract] [Full Text] [Related]

  • 24. [A study on effectiveness of treatment and prevention of relapse using topical administration of terbinafine in a guinea pig model for tinea pedis].
    Uchida K, Kudoh M, Yamaguchi H.
    Jpn J Antibiot; 1994 Oct; 47(10):1407-12. PubMed ID: 7807700
    [Abstract] [Full Text] [Related]

  • 25. Butenafine and superficial mycoses: current status.
    Singal A.
    Expert Opin Drug Metab Toxicol; 2008 Jul; 4(7):999-1005. PubMed ID: 18624686
    [Abstract] [Full Text] [Related]

  • 26. One week terbinafine 1% cream (Lamisil) once daily is effective in the treatment of interdigital tinea pedis: a vehicle controlled study. LAS-INT-06 Study Group.
    Korting HC, Tietz HJ, Bräutigam M, Mayser P, Rapatz G, Paul C.
    Med Mycol; 2001 Aug; 39(4):335-40. PubMed ID: 11556763
    [Abstract] [Full Text] [Related]

  • 27. A randomized, double-blind, vehicle-controlled efficacy and safety study of naftifine 2% cream in the treatment of tinea pedis.
    Parish LC, Parish JL, Routh HB, Fleischer AB, Avakian EV, Plaum S, Hardas B.
    J Drugs Dermatol; 2011 Nov; 10(11):1282-8. PubMed ID: 22052309
    [Abstract] [Full Text] [Related]

  • 28. Efficacy and safety of 1 % terbinafine film-forming solution in Chinese patients with tinea pedis: a randomized, double-blind, placebo-controlled, multicenter, parallel-group study.
    Li RY, Wang AP, Xu JH, Xi LY, Fu MH, Zhu M, Xu ML, Li XQ, Lai W, Liu WD, Lu XY, Gong ZQ.
    Clin Drug Investig; 2014 Mar; 34(3):223-30. PubMed ID: 24477462
    [Abstract] [Full Text] [Related]

  • 29. Effects of butenafine hydrochloride, a new benzylamine derivative, on experimental tinea pedis in guinea pigs.
    Arika T, Yokoo M, Maeda T, Amemiya K, Yamaguchi H.
    Antimicrob Agents Chemother; 1990 Nov; 34(11):2254-5. PubMed ID: 2073117
    [Abstract] [Full Text] [Related]

  • 30. Butenafine hydrochloride (Mentax) cream for the treatment of hyperkeratotic type tinea pedis and its transfer into the horny layer, with or without concomitant application of 20% urea ointment (Keratinamin).
    Tanuma H, Doi M, Ohta Y, Abe M, Kume H, Mukai H, Katsuoka K.
    Mycoses; 2001 Nov; 44(7-8):287-99. PubMed ID: 11714064
    [Abstract] [Full Text] [Related]

  • 31. Efficacy and safety of butenafine in superficial dermatophytoses (tinea pedis, tinea cruris, tinea corporis).
    Saple DG, Amar AK, Ravichandran G, Korde KM, Desai A.
    J Indian Med Assoc; 2001 May; 99(5):274-5. PubMed ID: 11676116
    [Abstract] [Full Text] [Related]

  • 32. Tinea pedis: clinical experience and efficacy of short treatment.
    Evans EG.
    Dermatology; 1997 May; 194 Suppl 1():3-6. PubMed ID: 9154392
    [Abstract] [Full Text] [Related]

  • 33. Management of toenail onychomycosis with 2% butenafine and 20% urea cream: a placebo-controlled, double-blind study.
    Syed TA, Ahmadpour OA, Ahmad SA, Shamsi S.
    J Dermatol; 1998 Oct; 25(10):648-52. PubMed ID: 9830263
    [Abstract] [Full Text] [Related]

  • 34. Efficacy, tolerability and consumer acceptability of terbinafine topical spray versus terbinafine topical solution: a phase IIa, randomised, observer-blind, comparative study.
    Brown M, Evans C, Muddle A, Turner R, Lim S, Reed J, Traynor M.
    Am J Clin Dermatol; 2013 Oct; 14(5):413-9. PubMed ID: 23740211
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Treatment of chronic tinea pedis (athlete's foot type) with topical terbinafine.
    Savin RC.
    J Am Acad Dermatol; 1990 Oct; 23(4 Pt 2):786-9. PubMed ID: 2229524
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Topical treatment of interdigital tinea pedis: terbinafine compared with clotrimazole.
    Patel A, Brookman SD, Bullen MU, Marley J, Ellis DH, Williams T, Barnetson RS.
    Australas J Dermatol; 1999 Nov; 40(4):197-200. PubMed ID: 10570555
    [Abstract] [Full Text] [Related]

  • 40. Butenafine: an update of its use in superficial mycoses.
    Gupta AK.
    Skin Therapy Lett; 2002 Sep; 7(7):1-2, 5. PubMed ID: 12432425
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.